Health-related quality of life outcomes for the LEAP Study - Alliance 70305: a lymphedema prevention intervention trial for newly-diagnosed breast cancer patients
- Citation:
- Qual Life Res vol 27 (suppl 1) abst 2019
- Meeting Instance:
- ISOQOL 2018
- Year:
- 2018
- Type:
- Abstract
- Sub type:
- Poster Discussion
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3144
- Program:
- CCP
- Primary Committee:
- Health Outcomes
- Sec. Committees:
- Breast Symptom Inter
- Pharmas:
- Grants:
- UG1CA189823, UG1CA189817, UG1CA189819, U10CA180790, U10CA180836, U10CA180850, UL1TR001409
- Corr. Author:
- Authors:
- MJ Naughton DK Seisler JA Sloan H Liu J Le-Rademacher J Oliveri JM Armer G Unzeitig M Schwartz M Melnik JR Taylor ED Paskett
- Networks:
- CRCWM, HEARTLAND, LAPS-MN026, LAPS-OH007, LAPS-WI020, MO036, TX190
- Study
- CALGB-70305
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: